Burnaby, Canada

Juliette Sabbatani

This inventor holds 1 USPTO granted patent and 8 published patent applications. Top assignee: Xenon Pharmaceuticals Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juliette Sabbatani. Retrieved from https://idiyas.com/inventor/juliette-sabbatani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Juliette Sabbatani

Introduction

Juliette Sabbatani is a notable inventor based in Burnaby, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of sodium channel activators.

Latest Patents

Juliette holds a patent for "Pyridine derivatives and their use as sodium channel activators." This patent is directed to compounds of formula (1), showcasing her innovative approach to enhancing sodium channel activity.

Career Highlights

Juliette is currently employed at Xenon Pharmaceuticals Inc., where she continues to advance her research and development efforts. Her work focuses on creating novel compounds that can have therapeutic applications.

Collaborations

Juliette has collaborated with notable colleagues, including Verner Alexander Lofstrand and Jung Yun Kim, contributing to a dynamic research environment.

Conclusion

Juliette Sabbatani's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions, particularly in sodium channel activators, highlight her role as a leading inventor in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…